TRUP vs. UTHR

The year-to-date returns for both stocks are quite close, with TRUP having a 66.27% return and UTHR slightly lower at 63.53%. Over the past 10 years, TRUP has outperformed UTHR with an annualized return of 22.33%, while UTHR has yielded a comparatively lower 10.72% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Trupanion, Inc. (TRUP) and United Therapeutics Corporation (UTHR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current TRUP Sharpe Ratio is 0.81, which is lower than the UTHR Sharpe Ratio of 2.10. The chart below compares the historical Sharpe Ratios of TRUP and UTHR, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither TRUP nor UTHR has paid dividends to shareholders.

The maximum TRUP drawdown since its inception was -87.34%, smaller than the maximum UTHR drawdown of -93.18%. Use the drawdown chart below to compare losses from any high point for TRUP and UTHR. For additional features, visit the drawdowns tool.

Trupanion, Inc. (TRUP) has a higher volatility of 14.75% compared to United Therapeutics Corporation (UTHR) at 8.49%. This indicates that TRUP's price experiences larger fluctuations and is considered to be riskier than UTHR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Trupanion, Inc. and United Therapeutics Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.